HCG (Human Chorionic Gonadotropin)
Diagnostic Applications in Reproductive Health and Oncology
Overview
Human Chorionic Gonadotropin (HCG) is a critical hormone used to diagnose early pregnancy and monitor pregnancy-related disorders. Its measurement is critical not only for establishing pregnancy, but also for diagnosing specific trophoblastic tumors and other HCG-secreting disorders.
Key Diagnostic Applications
- Increased HCG levels – Elevated HCG levels may indicate:
- Early pregnancy: verifying gestation
- Trophoblastic disorders include hydatidiform mole, malignant mole, and choriocarcinoma.
- HCG-secreting tumors include seminoma, teratoma, and some malignancies of the stomach, pancreas, lung, colon, liver, ovary, and digestive system.
- Reduced HCG levels: Lower HCG levels could indicate:
- Miscarriage can assist determine the viability of a pregnancy.
- Monitoring the treatment outcomes for pregnancy-related problems.
Importance in Clinical Practice
- Early Detection: HCG testing enables for accurate pregnancy confirmation and, if necessary, early intervention.
- Changes in HCG levels can assist track disease development or regression in trophoblastic tumors and some malignancies.
- Differential Diagnosis: HCG testing helps to distinguish between normal and abnormal pregnancy circumstances.
Summary
HCG is an important diagnostic biomarker in reproductive health and oncology. Its levels provide critical information about early pregnancy, pregnancy-related disorders, and HCG-secreting tumors, making it a valuable tool for physicians and healthcare professionals.




